Oxidized LDL, lipoprotein (a) and other emergent risk Factors in Acute Myocardial Infarction (FORTIAM study);LDL oxidada, lipoproteína(a) y otros factores de riesgo emergentes en el infarto agudo de miocardio (estudio FORTIAM)

Revista Espanola de Cardiologia

Volumn 62, Issue 4, 2009, Pages 373-382

  Gómez, Miquel ^a   Valle, Vicente ^b   Arós, Fernando ^c   Sanz, Ginés ^d   Sala, Joan ^e   Fiol, Miquel ^f   Bruguera, Jordi ^a   Elosua, Roberto ^g   Molina, Lluís ^a   Martí, Helena ^g   Isabel Covas, M ^g   Rodríguez Llorián, Andrés ^h   Fitó, Montserrat ^g   Suárez Pinilla, Miguel A ^h   Amezaga, Rocío ⁱ   Marrugat, Jaume ^g  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^h Hospital de Asturias   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

LDL cholesterol; Lipo proteins; Myocardial infarction; Prognosis

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGINA PECTORIS; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHLAMYDIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; ENDPOINT DETERMINATION; FEMALE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS;

EID: 66549106094     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70894-2     Document Type: Article

References (29)

1. U. Khot, M. Khot, C. Bajzer, S. Sapp, E. Ohman, and S. Brener Prevalence of conventional risk factors in patients with coronary heart disease JAMA 290 2003 898 904 (Pubitemid 37430461)
2. P. Greenland, M. Knoll, J. Stamler, J. Neaton, A. Dyer, and D. Garside Major risk factors as antecedents of fatal and nonfatal coronary heart disease events JAMA 290 2003 891 897 (Pubitemid 37430460)
3. M. Fiol, A. Cabades, J. Sala, J. Marrugat, R. Elosua, and G. Vega Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda) Rev Esp Cardiol 54 2001 443 452 (Pubitemid 33622000)
4. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum, and F. Lanas Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study) Lancet 64 2004 937 952 (Pubitemid 39208455)
5. D. Hackam, and S. Anard Emerging risk factors for atherosclerotic vascular disease JAMA 290 2003 932 940
6. A. Rosengren, L. Wilhelmsen, E. Eriksson, and B. Risberg Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men BMJ 301 1990 1248 1251
7. E. Braunwald Cardiovacular medicine at the turn of the millennium: triumphs, concerns and opportunities N Engl J Med 337 1997 1360 1369 (Pubitemid 27467771)
8. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795 (Pubitemid 24283962)
9. S. Tsimikas, H.K. Lau, K.R. Han, B. Shortal, E.R. Miller, and A. Segev Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): Short-term and long-term immunologic responses to oxidized low-density lipoprotein Circulation 109 2004 3164 3170
10. S. Tsimikas, E. Brilakis, E. Miller, J. McConnell, R. Lennon, and K. Kornman Oxidized phospholipids, lp(a) lipoprotein, and coronary artery disease N Engl J Med 353 2005 46 57 (Pubitemid 41007806)
11. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population Circulation 112 2005 651 657 (Pubitemid 41099043)
12. E. Armstrong, D. Morrow, and M. Sabatine Inflammatory biomarkers in acute coronary syndromes. Part III. Biomarkers of oxidative stress and angiogenic growth factors Circulation 113 2006 289 292
13. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
14. R. Elosua, J. Marrugat, L. Molina, S. Pons, and E. Pujol Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men Am J Epidemiol 139 1994 1197 1209 (Pubitemid 24184413)
15. R. Elosua, M. Garcia, A. Aguilar, L. Molina, M. Covas, and J. Marrugat Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish women. MARATHOM Group Med Sci Sports Exerc 32 2000 1431 1437 (Pubitemid 30618568)
16. L.G. Futterman, and L. Lemberg Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors Am J Crit Care 7 1998 240 244 (Pubitemid 128460540)
17. G. Dahlen, J. Boman, L. Birgander, and B. Lindblom Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease Atherosclerosis 114 1995 165 174
18. C.P. Cannon, E. Braunwald, C.H. McCabe, J.T. Grayston, B. Muhlestein, and R.P. Giugliano Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome N Engl J Med 352 2005 1646 1654 (Pubitemid 40530231)
19. V.M.G. Maher, and B.G. Brown Lipoprotein(a) and coronary heart disease Curr Op Lipidol 6 1995 229 235
20. T. Weinbrenner, M. Cladellas, M.I. Covas, M. Fito, M. Tomas, and M. Senti High oxidative stress in patients with stable coronary heart disease Atherosclerosis 168 2003 99 106 (Pubitemid 36555816)
21. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960 (Pubitemid 32322222)
22. S. Tsmikas, J. Witztum, E. Miller, W. Sasiela, M. Szarek, and A. Olsson High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial Circulation 110 2004 1406 1412 (Pubitemid 39238018)
23. R.S. Rosenson Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities Atherosclerosis 173 2004 1 12 (Pubitemid 38228462)
24. C.H. Saely, L. Koch, F. Schmid, T. Marte, S. Aczel, and P. Langer Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients Eur J Clin Invest 36 2006 91 97
25. P. Sánchez, M. Rodríguez, E. Villacorta, C. Albarran, I. Cruz, and J.M. Moreiras Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo Rev Esp Cardiol 59 2006 441 447 (Pubitemid 43949870)
26. J.A. Fournier, C. Delgado-Pellecin, A. Cayuela, S. Cabezón, and M.D. Mendoza La PCRas al mes de implantar un stent coronario metálico puede ser predictora de acontecimientos clínicos tardíos Rev Esp Cardiol 61 2008 313 316
27. M. Acevedo, P. Arnáiz, S. Barja, C. Bambs, X. Berríos, and B. Guzmán Proteína C reactiva y su relación con adiposidad, factores de riesgo cardiovascular y aterosclerosis subclínica en niños sanos Rev Esp Cardiol 60 2007 1051 1058 (Pubitemid 350305869)
28. A. Huelmos, J. Jiménez, C. Guijarro, J. Belinchón, E. Puras, and C. Sánchez Enfermedad arterial periférica desconocida en pacientes con síndrome coronario agudo: prevalencia y patrón diferencial de los factores de riesgo cardiovascular tradicionales y emergentes Rev Esp Cardiol 58 2005 1403 1410 (Pubitemid 43193355)
29. J. Danesh, J. Wheeler, G. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-Reactive Protein and other circulating markers of inflammation in the prediction of coronary heart disease N Eng J Med 350 2004 1387 1397 (Pubitemid 38419992)